lenalidomide has been researched along with Leukemia, Smoldering in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, Y; Furukawa, Y; Harada, N; Kumura, T; Manabe, M; Mugitani, A; Ohta, T; Okita, J; Tarakuwa, T | 1 |
| Afable, M; Englehaupt, R; List, AF; Maciejewski, JP; O'Keefe, C; Paulic, K; Sekeres, MA | 1 |
| Basinko, A; De Braekeleer, E; De Braekeleer, M; Douet-Guilbert, N; Le Bris, MJ; Morel, F | 1 |
1 review(s) available for lenalidomide and Leukemia, Smoldering
| Article | Year |
|---|---|
der(5;17)(p10;q10) is a recurrent but rare whole-arm translocation in patients with hematological neoplasms: a report of three cases.
Topics: Aged; Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cell Transformation, Neoplastic; Chromosome Aberrations; Chromosome Banding; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 5; Contraindications; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Karyotype; Lenalidomide; Leukemia, Myelomonocytic, Chronic; Lymphoma, T-Cell, Peripheral; Male; Megakaryocytes; Myelodysplastic Syndromes; Neoplasms, Second Primary; Recurrence; Remission Induction; Thalidomide; Translocation, Genetic | 2014 |
1 trial(s) available for lenalidomide and Leukemia, Smoldering
| Article | Year |
|---|---|
Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes.
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Azacitidine; Humans; Lenalidomide; Male; Middle Aged; Risk Factors; Thalidomide | 2011 |
1 other study(ies) available for lenalidomide and Leukemia, Smoldering
| Article | Year |
|---|---|
Distinct clonal deletions of the long arm of chromosome 5 in a patient with myelodysplastic syndrome.
Topics: Adjuvants, Immunologic; Aged, 80 and over; Anemia, Refractory, with Excess of Blasts; Blood Transfusion; Chromosome Deletion; Chromosomes, Artificial, Bacterial; Chromosomes, Human, Pair 5; Clone Cells; Female; Humans; In Situ Hybridization, Fluorescence; Lenalidomide; Thalidomide | 2012 |